From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Fairmount Healthcare Fund II L.P.

The investment firm revealed a purchase of 476,190 shares of Viridian Therapeutics Inc $VRDN, equivalent to $9.9 million.

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club.

We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week, via multiple reports.

Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

Today is Day Two for the All Star Charts team hosting our Portfolio Accelerator event in New York City.

During our group conversations today, Strazza and I put our heads together and put on this trade in Snowflake $SNOW.

For the past seven weeks, it was “do-or-die” for my favorite football team, the Buffalo Bills.

They came into the season as one of the favorites to make it to the Super Bowl. Las Vegas even had them at good odds to win it all for the first time in franchise history.

Of course, nobody can predict the future. Not in sports, not in markets, not anywhere.

And naturally, the real world had different ideas.

Twelve games into the seventeen-game season, it looked like all was lost and Bills fans would have to “wait ’til next year” once again. The Bills’ record was just 6-6 and they were looking up at 10 teams ahead of them in line for only 7 available playoff spots.

It looked like it was over. They faced a situation where their only real path to make it to the playoffs was to win their final five games. And those final five games were scheduled against a gauntlet of teams who were locks for the playoffs already — each with their own valid dreams of winning the Super Bowl.

In today's Daily Digest, we'll review:

1. No new positions.
2. Defensive adjustment in SMH.
3. No exits since last report.
4. Current status of open campaigns.

Let's dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Joseph D. Samberg, director of NextNav Inc $NN.

Samberg revealed a purchase of $1,172,775 worth of NN shares.

Hey folks...

The entire All Star Charts team is presently in NYC hosting our Portfolio Accelerator event. So I will skip the preamble and get right to the point for today's trade in $TSM...

In today's Daily Digest, we'll review:

1. No new positions.
2. Rolled TLT.
3. No exits since last report.
4. Current status of open campaigns.

Let's dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a 13G filing by Citadel Advisors.

The hedge fund revealed an initial stake of 5.20% in NETSTREIT Corp $NTST.

From the Desk of Steve Strazza @Sstrazza.

Welcome back to Under the Hood, where we'll cover all the action for the week ended January 19, 2024. This report is published bi-weekly, in rotation with The Minor Leaguers.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.

In today's Daily Digest, we'll review:

1. New position in GDX.
2. No Adjustments Today
3. Exits in USO and ARKK
4. Current status of open campaigns.

Let's dig in!

From the Desk of Ian Culley @IanCulley

First, gold failed to hold its breakout to new all-time highs.

Then, the silver-to-gold ratio undercut a critical shelf of former lows.

Now, the Gold Miners ETF $GDX is printing a new all-time low versus the broader market!

Is there any sane reason to bet on the miners right now?

Let’s take a look…

Check out GDX relative to the S&P 500 ETF $SPY: